Biotec Pharmacon ASA (OSL:BIOTEC) Mandatory Notification Of Trade

Biotec Pharmacon ASA (OSL:BIOTEC) Sven Rohmann, Vice President Business Development at Biotec Pharmacon, has bought 24000 shares in the company at an average price of 11.6208 NOK per share. After this transaction Sven Rohmann owns 24 000 shares in Biotec Pharmacon.

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Biotec Pharmacon ASA

http://www.biotec.no

ISIN: NO0010014632

Stock Identifier: XOSL.BIOTEC